
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States
Author(s) -
Steven D. Pinkerton,
Jeffrey N. Martin,
Michelle E. Roland,
Mitchell H. Katz,
Thomas J. Coates,
James O. Kahn
Publication year - 2004
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200410210-00011
Subject(s) - medicine , cost effectiveness , population , epidemiology , zidovudine , demography , environmental health , human immunodeficiency virus (hiv) , immunology , viral disease , risk analysis (engineering) , sociology
To evaluate the cost-effectiveness of HIV postexposure prophylaxis (PEP) following sexual or injection-related exposures in 96 metropolitan statistical areas in the United States (MSA).